BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2955760)

  • 21. Lipid peroxidative damage in the erythrocytes and elevation of serum LDL-cholesterol, apolipoprotein-B, ferritin and uric acid with age and in coronary heart disease patients.
    El-Gebali HH; Tahir SA; Haider SS; El-Fakhri MM
    Saudi Med J; 2000 Feb; 21(2):184-9. PubMed ID: 11533779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Follow-up of hemorheological parameters and platelet aggregation in patients with acute coronary syndromes.
    Marton Z; Horvath B; Alexy T; Kesmarky G; Gyevnar Z; Czopf L; Habon T; Kovacs L; Papp E; Mezey B; Roth E; Juricskay I; Toth K
    Clin Hemorheol Microcirc; 2003; 29(2):81-94. PubMed ID: 14610303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Plasma fibrinogen during the acute stage of angina or myocardial infarct].
    de la Llata-Romero M; Cancino C; Cuan V; López-Santibáñez J; Silvia Oropeza E; Ariza-Andraca H
    Gac Med Mex; 1997; 133(3):175-80; discussion 181. PubMed ID: 9303865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevation of vascular endothelial growth factor-A serum levels following acute myocardial infarction. Evidence for its origin and functional significance.
    Kranz A; Rau C; Kochs M; Waltenberger J
    J Mol Cell Cardiol; 2000 Jan; 32(1):65-72. PubMed ID: 10652191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Biochemical-physical and rheologic changes in the blood of patients with angina pectoris].
    Granato Corigliano G; Accadia M; Spadaro P
    Minerva Cardioangiol; 1993 May; 41(5):173-6. PubMed ID: 8355856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changes in serum malondialdehyde-modified low-density lipoprotein in patients with acute myocardial infarction and stable angina pectoris treated by coronary angioplasty].
    Araki T; Kanaya H; Shimizu M; Mabuchi H; Kitayama M; Kanemitsu S; Takekoshi N;
    J Cardiol; 2001 Aug; 38(2):55-60. PubMed ID: 11525110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of serum lipoprotein(a) with the clinical presentation of Thai coronary artery disease patients.
    Leowattana W; Mahanonda N; Bhuripanyo K; Pokum S; Worawattananon P
    J Med Assoc Thai; 2000 Nov; 83 Suppl 2():S194-8. PubMed ID: 11194014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between blood viscosity and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Cecchi E; Liotta AA; Gori AM; Valente S; Giglioli C; Lazzeri C; Sofi F; Gensini GF; Abbate R; Mannini L
    Int J Cardiol; 2009 May; 134(2):189-94. PubMed ID: 18495262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronary collateral circulation is less developed when ischaemic heart disease coexists with diabetes.
    Rzeczuch K; Jagielski D; Kołodziej A; Kaczmarek A; Mielnik M; Banasiak W; Ponikowski P
    Kardiol Pol; 2003 Feb; 58(2):85-92. PubMed ID: 14504633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma lipids and blood viscosity in patients with cerebrovascular disease.
    Velcheva I; Antonova N; Dimitrova V; Dimitrov N; Ivanov I
    Clin Hemorheol Microcirc; 2006; 35(1-2):155-7. PubMed ID: 16899921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease?
    Vayá A; Ricart J; Todolí J; Micó L; Contreras T; Aznar J
    Clin Hemorheol Microcirc; 2004; 30(3-4):411-4. PubMed ID: 15258375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hemorheologic therapy applications in coronary heart disease].
    Leschke M; Motz W; Strauer BE
    Wien Med Wochenschr; 1986; 136 Spec No():17-24. PubMed ID: 3825169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levels of antithrombin III, alpha 2-macroglobulin, and alpha 1-antitrypsin in acute ischemic heart disease.
    Losito R; Gattiker H; Bilodeau G; Verville N; Longpré B
    J Lab Clin Med; 1981 Feb; 97(2):241-50. PubMed ID: 6161197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum levels of lipids and apolipoproteins in angiographycally defined ischemic heart disease.
    Shima K; Tanaka A; Ejiri N; Maezawa H
    Bull Tokyo Med Dent Univ; 1985 Dec; 32(4):169-77. PubMed ID: 3865743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood pressure at health screening as a predictor of coronary heart disease in Kyoto.
    Sasaki S; Nakamura K; Uchida A; Fujita H; Itoh H; Nakata T; Takeda K; Nakagawa M
    J Cardiovasc Risk; 1996 Feb; 3(1):77-82. PubMed ID: 8783034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased plasma levels of fibrinogen in acute and chronic ischemic coronary syndromes.
    Abrignani MG; Novo G; Di Girolamo A; Caruso R; Tantillo R; Braschi A; Braschi GB; Strano A; Novo S
    Cardiologia; 1999 Dec; 44(12):1047-52. PubMed ID: 10687254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of hypertension and other risk factors in ischemic heart disease.
    Khadaker RK
    Chin Med J (Engl); 1993 May; 106(5):390-2. PubMed ID: 8404284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemorheological disturbances and characteristic parameters in patients with cerebrovascular disease.
    Antonova N; Velcheva I
    Clin Hemorheol Microcirc; 1999; 21(3-4):405-8. PubMed ID: 10711777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coagulation activation and expression of CD40 ligand on platelets upon in vitro lipopolysaccharide-challenge in patients with unstable angina.
    Kälsch T; Nguyen XD; Elmas E; Grebert N; Süselbeck T; Klüter H; Borggrefe M; Dempfle CE
    Int J Cardiol; 2006 Aug; 111(2):217-23. PubMed ID: 16182391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.